Effects of oral nutritional supplementation on the intestinal mucosa of patients with AIDS.
Weight loss is a major component of the clinical syndrome in patients with acquired immunodeficiency syndrome (AIDS). The impact of malnutrition on the outcome of the disease has been unappreciated in many investigations. The authors evaluated the effects of oral nutritional supplementation on the morphology and immunology of the intestinal mucosa of patients with AIDS. Twelve patients with AIDS without diarrhea or opportunistic infections, with at least 10% of body weight loss over 1 year, were submitted to anthropometric measures, peripheral blood T-lymphocyte counts, and peroral jejunal biopsy before and after oral nutritional supplementation. An industrialized peptide-based formula containing omega-3 fatty acids was given for 6 weeks. Jejunal samples were analyzed by histomorphometry, including villous-to-crypt ratio, lamina propria, and intraepithelial lymphocyte count. Immunologic assessment of the intestinal mucosa was made by indirect immunoperoxidase using monoclonal antibodies against CD3, CD4, and CD8. Seven patients with irritable bowel syndrome and two healthy volunteers were selected as a control group for histologic and immunohistochemical comparisons. After 6 weeks the patient group maintained their body weight and increased their tricipital fold. The number of peripheral blood T cells, albumin, transferrin, and the number of CD3+, CD4+, and CD8+ cells in jejunal mucosa as well as the intestinal morphometry remained stable. Oral supplementation contributed to maintaining body weight and may constitute a reasonable adjuvant therapeutic tool against AIDS progression.
Fogaça
H
H
Multidisciplinary Laboratory, University Hospital, Federal University of Rio de Janeiro, Brazil.
Souza
H
H
Carneiro
A J
AJ
Carvalho
A T
AT
Pimentel
M L
ML
Papelbaum
M
M
Elia
P
P
Elia
C
C
D000163:Acquired Immunodeficiency Syndrome / Q000473:pathology*; D000328:Adult; D001835:Body Weight / Q000187:drug effects; D019587:Dietary Supplements; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D007413:Intestinal Mucosa / Q000378:metabolism* / Q000473:pathology*; D007583:Jejunum / Q000378:metabolism / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects